--- title: "Pre-market hot trades in US stocks: Entegris up 7.78% pre-market; Navitas Semiconductor up 7.03% pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/294819281.md" description: "Entegris pre-market up 7.78%; Navitas Semiconductor pre-market up 7.03%; TNL Mediagene pre-market up 112.64%; RISING DRAGON ACQUISITION CORP COM USD0.0001 15/11/2028 (SUBS/RT) pre-market up 88.01%; Adagio Medical pre-market up 59.65%" datetime: "2026-08-04T11:53:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294819281.md) - [en](https://longbridge.com/en/news/294819281.md) - [zh-HK](https://longbridge.com/zh-HK/news/294819281.md) --- # Pre-market hot trades in US stocks: Entegris up 7.78% pre-market; Navitas Semiconductor up 7.03% pre-market **Pre-market Hot Trades in US Stocks** Entegris is up 7.78% in pre-market trading. Based on recent key news: 1. On August 4, Entegris announced its second-quarter financial report, with sales reaching $883 million, exceeding market expectations. The company's operating income was $164.6 million, and gross profit was $420 million, driving the stock price up. Source: Reuters 2. On August 4, Entegris released a press release, expecting third-quarter sales to be between $905 million and $935 million, surpassing market consensus. The company anticipates non-GAAP earnings per share to be between $0.96 and $1.04, reflecting strong profitability. Source: Entegris Press Release 3. On August 4, Entegris' CEO stated that the company achieved double-digit growth against the backdrop of increased semiconductor demand and greater customer investment, with a successful operational strategy further boosting market confidence. Source: Business Wire Strong demand in the semiconductor industry and increased investment. Navitas Semiconductor is up 7.03% in pre-market trading. There has been no significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no\_news **Top Gainers in Pre-market US Stocks** TNL Mediagene is up 112.64% in pre-market trading. Based on recent key news: 1. On August 2, TNL Mediagene announced plans to fund its large-scale commercialization efforts by issuing $500 million in convertible senior notes. This move is seen as a strategic effort by the company to raise funds in the capital markets to address operational impacts, significantly boosting the stock price. 2. On August 3, the market reacted positively to TNL Mediagene's forward-looking statements, although the company cautioned investors not to rely on these statements as future guidance, investor optimism about its growth potential still drove the stock price. 3. On August 4, TNL Mediagene's stock continued to attract market attention, despite no new major announcements, as investor interest in its commercialization plans maintained the stock price at high levels. Challenges in capital market fundraising have intensified. RISING DRAGON ACQUISITION CORP COM USD0.0001 15/11/2028 (SUBS/RT) is up 88.01% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Adagio Medical is up 59.65% in pre-market trading. Based on recent key news: 1. On August 4, Adagio Medical had a market capitalization of approximately $10.17 million, with its stock price down about 66.42% over the past 12 months. Benzinga Edge's stock rankings show negative price trends in the short, medium, and long term, which may lead to investor concerns about its future performance 2. On August 3rd, Adagio Medical Holdings Inc. released new information through Business Wire, emphasizing its future forward-looking statements and stating that it will update these statements as required by law. This may trigger market attention to its future plans. 3. On August 3rd, Adagio Medical provided additional information in other SEC filings, which may raise further investor concern about its financial condition and future plans. The market holds a cautious attitude towards Adagio Medical's future performance ### Related Stocks - [ENTG.US](https://longbridge.com/en/quote/ENTG.US.md) - [NVTS.US](https://longbridge.com/en/quote/NVTS.US.md) - [TNMG.US](https://longbridge.com/en/quote/TNMG.US.md) - [RDACR.US](https://longbridge.com/en/quote/RDACR.US.md) - [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md) ## Related News & Research - [NewEdge Advisors LLC Has $951,000 Holdings in Entegris, Inc. $ENTG](https://longbridge.com/en/news/296326213.md) - [Entegris SVP, General Counsel Joseph Colella disposes of 3,916 common shares worth $644,107.68](https://longbridge.com/en/news/295962977.md) - [Top Entegris Executive Makes Notable Move With Fresh Stock Sale](https://longbridge.com/en/news/295737707.md) - [Entegris SVP Global Human Resources Susan G. Rice sells 2,062 shares worth $308,706.24](https://longbridge.com/en/news/295694734.md) - [Entegris says Taiwan, China uphold validity of CMP slurry patents](https://longbridge.com/en/news/296218041.md)